Expansion financing TEN Healthcare recently secured 1.3 million in financing for expansion, signaling growth plans and a potential need for additional lab capacity, equipment upgrades, or service contracts to support scalable infectious disease testing.

Infectious disease focus With specialization in high complexity infectious disease testing using qPCR, there is a clear opportunity to cross-sell complementary molecular assays, validation services, or data management solutions tailored to high-throughput pathogen testing workflows.

Clinical testing scope Beyond infectious disease, TEN Healthcare provides urine and saliva analysis for prescription drug monitoring and clinical blood testing, suggesting avenues for partnerships in analytics services, LIMS integrations, or expanded credentialing for regulated specimen workflows.

Tech and cloud Utilizes multiple cloud and collaboration platforms (Google Cloud, Microsoft Azure, Squarespace/WordPress, Mimecast, Paylocity), indicating receptivity to cloud-based labs IT solutions, cybersecurity hardening, and integrated payroll/HR solutions for a growing science operation.

Growth potential Revenue in the mid tens of millions and staff in the 11–50 range imply scale-up opportunities in contract research, service-level agreements, and managed services for a regional lab expanding its client base, with possible emphasis on compliance, QA, and rapid turnaround capabilities.